Human CTGF / CCN2 Protein, His Tag
分子別名(Synonym)
CCN2,NOV2,HCS24,IGFBP8,IBP-8,IGFBP-8,IGF-binding protein 8
表達(dá)區(qū)間及表達(dá)系統(tǒng)(Source)
Human CTGF, His Tag (CTF-H52H5) is expressed from human 293 cells (HEK293). It contains AA Gln 27 - Ala 349 (Accession # Q5M8T4-1).
Predicted N-terminus: Gln 27
蛋白結(jié)構(gòu)(Molecular Characterization)

This protein carries a polyhistidine tag at the C-terminus.
The protein has a calculated MW of 37.4 kDa. The protein migrates as 36-45 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
內(nèi)毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method.
純度(Purity)
>90% as determined by SDS-PAGE.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in Tris with Potassium glutamate and Arginine, pH7.0 with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(chǔ)(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.


背景(Background)
結(jié)締組織生長(zhǎng)因子(CTGF),也稱(chēng)為CCN2,是模塊化基質(zhì)細(xì)胞蛋白CCN(CCN1-6)家族的成員。與其他CCN蛋白一樣,成熟的人CTGF由IGF結(jié)合蛋白結(jié)構(gòu)域、vWF-C結(jié)構(gòu)域、TSP-1結(jié)構(gòu)域和半胱氨酸結(jié)肝素結(jié)合結(jié)構(gòu)域組成。CTGF促進(jìn)軟骨細(xì)胞的增殖和分化。在許多細(xì)胞類(lèi)型中介導(dǎo)肝素和二價(jià)陽(yáng)離子依賴(lài)性細(xì)胞粘附,包括成纖維細(xì)胞、肌成纖維細(xì)胞,內(nèi)皮細(xì)胞和上皮細(xì)胞。增強(qiáng)成纖維細(xì)胞生長(zhǎng)因子誘導(dǎo)的DNA合成。CCN2在體內(nèi)的功能分析主要集中在其作為多種纖維化疾病中過(guò)量ECM合成的介質(zhì)的關(guān)鍵作用上。
關(guān)鍵字: CTGF;CTGF蛋白;CTGF重組蛋白;ACRO;百普賽斯;
百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國(guó)生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺(tái)型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國(guó)、美國(guó)、瑞士等12個(gè)城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計(jì)服務(wù)客戶(hù)超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長(zhǎng)期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。